Bibliographic information
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
WHO recommends ART for all people with HIV and drug-resistant TB, requiring second-line anti-TB drugs irrespective of CD4 cell count, as early as possible (within the first eight weeks) following initiation of anti-TB treatment
Recommended in favor
Strong
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
Year2022
InstitutionWHO